A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
NCT05394259
Adenocarcinoma, Breast Cancer
Houston, Texas, United States
View Trial DetailsNCT Number: NCT06018857
This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From date of surgery to date of identified cancer recurrence through either clinical judgement or scans. This is assessed up to 10 years after the surgery.
Time frame: From date of surgery to date of death, up to 10 years after the surgery.
Federico Aucejo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05394259
Adenocarcinoma, Breast Cancer
Houston, Texas, United States
View Trial DetailsNCT06084884
Adenocarcinoma, Carcinoma
Phoenix, Arizona, United States
View Trial DetailsNCT04550481
Adenocarcinoma, Carcinoma
Los Angeles, California, United States
View Trial DetailsNCT03847428
Adenocarcinoma, Carcinoma
Birmingham, Alabama, United States
View Trial Details